Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial. (2017)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(17)30823-1

PubMed Identifier: 28385352

Publication URI: http://europepmc.org/abstract/MED/28385352

Type: Journal Article/Review

Volume: 389

Parent Publication: Lancet (London, England)

Issue: 10081

ISSN: 0140-6736